Testing for clostridium difficile in patients newly diagnosed with inflammatory bowel disease in a community setting

Inflammatory Bowel Diseases

Volumn 21, Issue 3, 2015, Pages 564-569

  Krishnarao, Anita ^a   De Leon, Lauren ^b   Bright, Renee ^b   Moniz, Heather ^b   Law, Meaghan ^b   Leleiko, Neal ^a,c   Sands, Bruce E ^d   Merrick, Marjorie ^e   Shapiro, Jason ^a,c   Wallenstein, Sylvan ^d   Giacalone, Julie ^d   Shah, Samir A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c HASBRO CHILDREN'S HOSPITAL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Crohn's and Colitis Foundation of America   (United States)

Author keywords

Clostridium difficile; Crohn's disease; inflammatory bowel disease; quality measures; ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; COMMUNITY; CROHN DISEASE; DELAYED DIAGNOSIS; DIARRHEA; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTIONS; DEMOGRAPHY; DIAGNOSTIC TEST; FECES; INFLAMMATORY BOWEL DISEASES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PEPTOCLOSTRIDIUM DIFFICILE; PRESCHOOL CHILD; PREVALENCE; PROCEDURES; PROGNOSIS; RISK FACTOR; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIAGNOSTIC TESTS, ROUTINE; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; NEW YORK; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS; YOUNG ADULT;

EID: 84923392655     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000309     Document Type: Article

References (20)

1. Kelly CA 76 year old man with recurrent Clostridium difficile associated diarrhea: review of C. difficile infection. JAMA. 2009; 301: 954-962.
2. Rodemann J, Dubberke E, Reske K, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 5: 339-344.
3. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008; 57: 205-210.
4. Chiplunker A, Ananthakrishnan AN, Beaulieu DB, et al. Long-term impact of Clostridium difficile on inflammatory bowel disease. Gastroenterology. 2009; 136(Suppl 1): A-199.
5. Jodorkovsky D, Young Y, Abreu MT. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci. 2010; 55: 415-420.
6. Jen MH, Saxena S, Bottle A, et al. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33: 1322-1331.
7. Nguyen GC, Kaplan GG, Harris ML, et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008; 103: 1443-1450.
8. Navaneethan U, Venkatesh PGK, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol. 2010; 16: 4892-4904.
9. Powell N, Jung SE, Krishnan B. Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent. Gut. 2008; 57: 1183-1184.
10. Kyne L, Sougioultzis S, McFarland LV, et al. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol. 2002; 23: 653-659.
11. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-Associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005; 173: 1037-1042.
12. Schneeweiss S, Korzenik J, Solomon DH, et al. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infection. Aliment Pharmacol Ther. 2009; 30: 253-264.
13. Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007; 17: 976-983.
14. Ananthakrishnan A. Detecting and treating Clostridium Difficile infections in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 2012; 41: 339-353.
15. Issa M, Ananthakrisnan A, Binion D. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14: 1432-1442.
16. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108: 478-498.
17. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol. 2009; 104: 465-483.
18. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010; 105: 501-523.
19. NIDDK Inflammatory Bowel Disease Genetics Consortium. Available at: http: //medicine.yale.edu/intmed/ibdgc/index.aspx. Accessed June 1, 2010.
20. Satsangi J, Silverberg MS, Vermiere S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753.